Anti-inflammatory treatments, such as the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, can help reduce leukocyte activation and ROS production
Avoid this treatment if: You have been diagnosed with type 1 diabetes You are pregnant, trying to become pregnant, or breastfeeding You have severe digestive conditions, including gastroparesis (delayed stomach emptying) You have an allergy to tirzepatide or any ingredient listed in the medication You are under 18 You should also speak to a healthcare professional before starting Mounjaro if you have any of the following, as extra caution or monitoring may be needed: A history of pancreatitis Gallbladder problems, including gallstones Significant kidney disease or dehydration risk (especially if you are prone to vomiting) Liver problems Diabetic eye disease (diabetic retinopathy), particularly if your blood sugars may change quickly A history of severe allergic reactions to injectable medicines You take other diabetes medications, especially insulin or sulfonylureas, as your risk of low blood sugar may be higher As with any prescription weight loss treatment, ongoing monitoring is important
We calculate optimistic and pessimistic scenarios by flexing these key assumptions to plausible higher and lower values
Enhancing metabolism to promote efficient fat burning
Annual Review of Nutrition
